NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea
· Delayed Price · Currency is KRW
1,198.00
+23.00 (1.96%)
Feb 21, 2025, 3:30 PM KST
NeoImmuneTech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 23,689 | 40,041 | 78,963 | 203,671 | - | - | |
| Market Cap Growth | -14.97% | -49.29% | -61.23% | - | - | - | |
| Enterprise Value | -12,592 | -37,279 | -56,272 | 42,088 | - | - | |
| Last Close Price | 1198.00 | 2025.00 | 3995.00 | 10350.00 | - | - | |
| PB Ratio | 12.99 | 0.53 | 0.66 | 1.26 | - | - | |
| P/TBV Ratio | 0.70 | 0.58 | 0.70 | 1.31 | - | - | |
| Debt / Equity Ratio | 0.09 | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 | |
| Quick Ratio | 3.75 | 5.36 | 7.14 | 7.57 | 7.91 | 35.93 | |
| Current Ratio | 4.12 | 5.61 | 7.19 | 8.17 | 8.96 | 36.48 | |
| Return on Equity (ROE) | -65.60% | -54.90% | -42.88% | -42.62% | -30.44% | -16.71% | |
| Return on Assets (ROA) | -32.40% | -30.30% | -22.25% | -22.95% | -18.02% | -11.52% | |
| Return on Capital (ROIC) | -39.99% | -34.34% | -24.87% | -25.45% | -18.99% | -11.74% | |
| Earnings Yield | -185.80% | -133.37% | -76.50% | -25.77% | - | - | |
| FCF Yield | -176.20% | -126.25% | -56.84% | -17.97% | - | - | |
| Buyback Yield / Dilution | -0.03% | -0.08% | -3.68% | -15.26% | -1.50% | -39.27% | |
| Total Shareholder Return | -0.03% | -0.08% | -3.68% | -15.26% | -1.50% | -39.27% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.